News
New Star Investment Trust PLC: MSCM-Miscellaneous - Listing Rule 15.6.8
New Star Investment Trust PLC: MSCM-Miscellaneous - Listing Rule 15.6.8
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
TechnipFMC to Address Attendees at the BofA Securities Global Energy Conference 2023
TechnipFMC (NYSE: FTI) announced today that Doug Pferdehirt, Chair and Chief Executive Officer, will address attendees on Tuesday, November 14, at 10:30 a.m. CST at the following event:
BofA
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
R.E.A. Holdings plc: dividend re 9 per cent cumulative preference shares
R.E.A. Holdings plc: dividend re 9 per cent cumulative preference shares
R.E.A. Holdings plc: Further investment by DSN in REA Kaltim
R.E.A. Holdings plc: Further investment by DSN in REA Kaltim
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
Form 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
Form 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through
LivaNova Reports Third-Quarter 2023 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2023 and raised full-year 2023 revenue and adjusted diluted
Edison issues update on Murray Income Trust (MUT): In a celebratory mood
Edison issues update on Murray Income Trust (MUT): In a celebratory mood
Chelverton UK Dividend Trust plc: Closed period announcement
Chelverton UK Dividend Trust plc: Closed period announcement
Rights and Issues Investment Trust PLC: TVR-Total Voting Rights
Rights and Issues Investment Trust PLC: TVR-Total Voting Rights
Halfords Group PLC: Halfords receives investment in its Avayler business, with Bridgestone taking a 5% stake
Halfords Group PLC: Halfords receives investment in its Avayler business, with Bridgestone taking a 5% stake